PHONE CASE MANUFACTURER P H O N E C A S E • Formulated TPE with 43% bio-based content plus favorable UV resistance and vibration damping performance compared to standard TPE • Received radiocarbon (C14) international certificate for bio-based content • Provided excellent bonding ability with good aesthetics • Matched design specs with an easily colored material using traditional TPE colorants reSoundTM OM TPEs WHY AVIENT?

FOOD PACKAGING MANUFACTURER C A N N I N G L I D S E A L S • Meet regulatory requirements for the application • Provide technical support including specific color, processing and molding recommendations • Deliver a high retort formulation to help preserve food quality and extend shelf life • Developed an FDA-compliant bio-derived plastisol to meet necessary regulatory specifications and help gain market share • Provided technical expertise throughout the design and manufacturing process • Offered a high retort solution with material strength and durability CORE™ Bio-based Vinyl Plastisols KEY REQUIREMENTS WHY AVIENT? All Rights Reserved. https://www.avient.com/products/vinyl-formulations/vinyl-plastisols-organosols/core-bio-based-vinyl-plastisols

View PDF The SQS herewith attests that the organisation named below has a management system that meets the requirements of the normative base mentioned. 70 01 _1 /A pr il 20 22 /V er si on 2 .0 Certificate Avient Colorants Germany GmbH Hohenrhein 1 56112 Lahnstein Germany Scope Production of Color Concentrates and Compounds Normative base ISO 50001:2018 Energy Management System Reg. no. 46089 Page 1 of 1 Validity 17. 12. 2023 – 16. 12. 2026 Issue 17. 12. 2023 A.Grisard, President SQS F.

View PDF The SQS herewith attests that the organisation named below has a management system that meets the requirements of the normative base mentioned. 70 01 _1 /A pr il 20 22 /V er si on 2 .0 Certificate Avient Colorants Spain S.A. Martorell no.124 08740 Sant Andreu de la Barca Spain Scope Category I Production of customer specific Masterbatches for Food packaging materials on the dedicated extrusion lines Normative base ISO 22000:2018 Food Safety Management Systems - Requirements for any organization in the food chain Reg. no. 46388 Page 1 of 1 Validity 25. 02. 2024 – 24. 02. 2027 Issue 25. 02. 2024 A.Grisard, President SQS F.

View PDF The SQS herewith attests that the organisation named below has a management system that meets the requirements of the normative base mentioned. 70 01 _1 /A pr il 20 22 /V er si on 2 .0 Certificate P.T. Cibodas 15138 Kecamatan Cibodas, Tangerang Indonesia Scope Category I Production of customer specific Masterbatches for Food packaging materials on the dedicated extrusion lines Normative base ISO 22000:2018 Food Safety Management Systems - Requirements for any organization in the food chain Reg. no. 46391 Page 1 of 1 Validity 25. 02. 2024 – 24. 02. 2027 Issue 25. 02. 2024 A.Grisard, President SQS F.

Based on nylon 6 (PA6) and nylon 66 (PA66) polymers, these materials combine high temperature performance with exceptional strength and durability. Formulations can also be customized based on customer requirements. CUSTOMIZED NYLON FEATURES Portfolio Name Base Filler Impact Modifiers Lubrication UV Heat Flame Retardant Approvals/ Listings Nymax/Bergamid Polymer Formulations Prime Glass Fiber Glass Bead Mineral Unfilled ✔ ✔ ✔ ✔ ✔ Automotive Approvals NSF Listings UL Listed Nymax REC Recycled Nylon Formulations Recycled Glass Fiber Mineral Unfilled ✔ ✔ ✔ ✔ Automotive Approvals NYMAX REC RECYCLED NYLON FORMULATIONS Nymax REC recycled nylon 6 and nylon 66 grades contain 20–100% recycled content from both post-industrial recycled (PIR) and post-consumer recycled (PCR) sources.

TECHNICAL BULLETIN reSound™ BIO Thermoplastic Elastomers Customizable Bio-based TPEs reSound™ BIO TPEs are formulated utilizing between 35 and 60 percent bio-renewable content. Developed to support growing sustainability goals, these bio- polymers offer hardness levels from 30-70 Shore A and property retention comparable to traditional petroleum-based TPEs. Avient can also develop custom bio-based formulations that expand on the initial reSound BIO portfolio.

SynPlicity™ 1000 cosmetic ester provides an excellent balance of performance and durability for nail polish formulations in a highly-efficient, non-phthalate and bio-based alternative to petroleum-derived plasticizers. SynPlicity™ 1000 cosmetic ester can help you achieve plasticizer usage levels and performance characteristics comparable to DBP, BBP and other high solvating plasticizers with a 94% bio-based, non-phthalate alternative. KEY CHARACTERISTICS • High solvating • Non-phthalate • Bio-based (derived from soybean oil) • Low viscosity • Low odor • Added flexibility and increased durability • INCI listed as Methyl Epoxidized Soyate www.polyone.com Copyright © 2016, PolyOne Corporation.

Avient does not produce commodity base resins. Note 14 — SHARE-BASED COMPENSATION Share-based compensation cost is based on the value of the portion of share-based payment awards that are ultimately expected to vest during the period. Share-based compensation expense is based on awards expected to vest and therefore has been reduced for estimated forfeitures.

• Review and approve corporate goals and objectives relevant to the Chief Executive Officer’s compensation; in conjunction with the evaluation conducted by the Board as described in the Company’s Corporate Governance Guidelines, evaluate the Chief Executive Officer’s performance in light of these goals and objectives; and determine and approve (or determine and approve, and recommend to the independent members of the Board for their determination and approval) the Chief Executive Officer’s compensation level based on this evaluation and comparable market data provided by an independent compensation consultant. • In determining the long-term incentive component of the Chief Executive Officer’s compensation, consider the Company’s performance and relative shareholder return, the value of similar incentive awards to chief executive officers at comparable companies, and the awards given to the Chief Executive Officer in the past. • Review and approve the compensation of other executive officers of the Company, including benefits and perquisites, taking into consideration the Company’s performance, comparable market data, the performance of each executive officer, and such other factors as may, in the Committee’s discretion, be appropriate. • In evaluating and making recommendations regarding, or determining and approving, executive compensation, the Committee shall consider the results of the most recent shareholder advisory vote on executive compensation (“Say on Pay Vote”) required by Section 14A of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). • With respect to incentive compensation plans and equity-based plans: • Make recommendations to the Board with respect to the approval of incentive compensation plans for executive officers and all equity-based plans. • Review and approve equity-based grants and awards, including long-term incentive plan awards, to officers, senior managers, key employees, and other employees of the Company and its subsidiaries under the Company’s equity-based plans. • Review and approve the performance criteria, target awards, payout criteria and like items for the Company’s long-term incentive compensation plans. • Review and approve (a) attainment levels for executive officers under the Company’s annual incentive plan; (b) payments to executive officers under the annual incentive plan; and (c) payments to executive officers under the Company’s long-term incentive compensation plans. • Administer the Company’s equity-based incentive compensation plans and other plans 3 adopted by the Board that contemplate administration by the Committee. • Review and approve special bonuses and/or other awards to executive officers on a case-by- case basis for outstanding performance. • Review and approve the terms of all employment agreements, management continuity agreements and change in control agreements for elected officers. Non-employee Director Compensation. • Review the compensation of non-employee directors and make recommendations to the Board regarding changes to existing compensation levels. • Perform administrative functions with respect to the compensation of non-employee directors, including interpreting existing policy. • Review and approve (or approve and recommend to the Board for its approval) equity-based grants and awards to non-employee directors under the Company’s equity-based plans. Review and Discuss the CD&A; Compensation Committee Report. • With the assistance of management and any outside advisers the Committee deems appropriate (a) review and discuss with management the Company’s disclosures in the CD&A, and, based on this review, make a recommendation as to whether to include it in the Company’s annual report on Form 10-K and proxy statement relating to the Company’s 4 annual meeting of shareholders, and (b) prepare a Compensation Committee Report for inclusion in the Company’s proxy statement or other applicable SEC filings.